Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pituitary neoplasia

S Melmed1

  • 1Division of Endocrinology and Metabolism, Cedars-Sinai Medical Center, Los Angeles School of Medicine, University of California.

Endocrinology and Metabolism Clinics of North America
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society.

Pituitary·2025
Same author

Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs).

Pituitary·2025
Same author

Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE).

Pituitary·2024
Same author

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers.

Pituitary·2023
Same author

Expression of leukemia inhibitory factor in craniopharyngioma.

Endocrine pathology·2016
Same author

Sagit©: A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Anterior pituitary tumors arise from a single cell and involve genetic changes, similar to those seen in MEN 1 tumors. Understanding these genetic defects offers new treatment and prognosis options for pituitary tumors.

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Anterior pituitary tumors can be clinically silent or secrete hormones causing disorders.
  • Hypothalamic hormones influence pituitary function and may promote tumor growth.
  • Pituitary tumors originate from a monoclonal source.

Purpose of the Study:

  • To explore the genetic underpinnings of pituitary tumorigenesis.
  • To investigate similarities between sporadic and MEN 1-associated pituitary tumors.
  • To highlight the potential for novel therapeutic and prognostic strategies.

Main Methods:

  • Review of genetic mutations in anterior pituitary tumors.
  • Analysis of oncogene activation and tumor suppressor gene loss.
  • Comparison of genetic defects in sporadic versus MEN 1-associated tumors.

Related Experiment Videos

Main Results:

  • Pituitary tumors are monoclonal, indicating a single cell of origin.
  • Activating oncogene mutations and tumor suppressor gene loss are implicated.
  • Sporadic pituitary tumors share genetic defects with MEN 1-associated tumors.

Conclusions:

  • Pituitary tumorigenesis is a multistep genetic process.
  • Understanding these genetic alterations is crucial for patient outcomes.
  • Novel prognostic and therapeutic avenues are emerging from genetic insights.